Elena Castro

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Systematic Review

Radical Prostatectomy

Circulating Tumor

Top Venues

International journal of molecular sciences

Therapeutic advances in medical oncology

Therapeutic advances in urology

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Teresa Bourlon, Paola Valdez, Elena Castro
Development of PARP inhibitors in advanced prostate cancer. Therapeutic advances in medical oncology 16 (2024)
Maria Teresa Bourlon, Paola Valdez, Elena Castro
Development of PARP inhibitors in advanced prostate cancer. Therapeutic advances in medical oncology 16 (2024)
María Dolores Fenor de la Maza, Jose Luis Pérez Gracia, Bernardino Miñana, Elena Castro
PARP inhibitors alone or in combination for prostate cancer. Therapeutic advances in urology 16 (2024)
María Dolores Fenor de la Maza, Jose Luis Pérez Gracia, Bernardino Miñana, Elena Castro
PARP inhibitors alone or in combination for prostate cancer. Therapeutic advances in urology 16 (2024)
Mariangela Calabrese, Isabella Saporita, Ursula Maria Vogl, Silke Gillessen, Elena Castro, Ursula Maria Vogl, Rosario Francesco Di Stefano, Federica Maria Carfì, Stefano Poletto, Giovanni Farinea, Marcello Tucci, Consuelo Buttigliero
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Mariangela Calabrese, Isabella Saporita, Ursula Maria Vogl, Silke Gillessen, Elena Castro, Ursula Maria Vogl, Rosario Francesco Di Stefano, Federica Maria Carfì, Stefano Poletto, Giovanni Farinea, Marcello Tucci, Consuelo Buttigliero
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Mariangela Calabrese, Isabella Saporita, Ursula Maria Vogl, Silke Gillessen, Elena Castro, Ursula Maria Vogl, Rosario Francesco Di Stefano, Federica Maria Carfì, Stefano Poletto, Giovanni Farinea, Marcello Tucci, Consuelo Buttigliero
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer. International journal of molecular sciences 25 (1) (2023)
Vilma Pacheco-Barcia, Andrés Muñoz, Elena Castro, Ana Isabel Ballesteros, Gloria Marquina, Iván González-Díaz, Ramon Colomer, Nuria Romero-Laorden
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair. Cancers 14 (12) (2022)
Andrisha-Jade Inderjeeth, Monique Topp, Elaine Sanij, Elena Castro, Shahneen Sandhu
Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer. Cancers 14 (23) (2022)
Niven Mehra, Karim Fizazi, Johann S de Bono, Philippe Barthélémy, Tanya Barauskas Dorff, Adam Stirling, Jean-Pascal Machiels, Davide Bimbatti, Deepak Kilari, Herlinde Dumez, Consuelo Buttigliero, Inge M van Oort, Elena Castro, Hsiang-Chun Chen, Nicola Di Santo, Liza DeAnnuntis, Cynthia G Healy, Giorgio Vittorio Scagliotti
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. The oncologist 27 (10) (2022)
Andrisha-Jade Inderjeeth, Monique Topp, Elaine Sanij, Elena Castro, Shahneen Sandhu
Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer. Cancers 14 (23) (2022)
Andrisha-Jade Inderjeeth, Monique Topp, Elaine Sanij, Elena Castro, Shahneen Sandhu
Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer. Cancers 14 (23) (2022)
Rebeca Lozano, David Lorente, Isabel M Aragon, Nuria Romero-Laorden, Paz Nombela, Joaquin Mateo, Alison H M Reid, Ylenia Cendón, Diletta Bianchini, Casilda Llácer Pérez, Shahneen K Sandhu, Adam Sharp, Pasquale Rescigno, Teresa Garcés, Maria I Pacheco, Penelope Flohr, Christophe Massard, Pedro P López-Casas, Elena Castro, Johann S de Bono, David Olmos
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients. Cancers 13 (10) (2021)
Carlo Cattrini, Rodrigo España, Alessia Mennitto, Melissa Bersanelli, Elena Castro, David Olmos, David Lorente Estellés, Alessandra Gennari
Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer. Cancers 13 (18) (2021)
Carlo Cattrini, Davide Soldato, Alessandra Rubagotti, Linda Zinoli, Elisa Zanardi, Paola Barboro, Carlo Messina, Elena Castro, David Olmos, Francesco Boccardo
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer. Cancers 12 (10) (2020)
Nigel Armstrong, Ruben G W Quek, Steve Ryder, Janine Ross, Titas Buksnys, Carol Forbes, Kathleen M Fox, Elena Castro
DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review. Future oncology (London, England) 17 (7) (2020)
Paz Nombela, Rebeca Lozano, Alvaro Aytes, Joaquin Mateo, David Olmos, Elena Castro
BRCA2 and Other DDR Genes in Prostate Cancer. Cancers 11 (3) (2019)
Carlo Cattrini, Elena Castro, Rebeca Lozano, Elisa Zanardi, Alessandra Rubagotti, Francesco Boccardo, David Olmos
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer. Cancers 11 (9) (2019)
Nuria Romero-Laorden, Rebeca Lozano, Anuradha Jayaram, Fernando López-Campos, Maria I Saez, Alvaro Montesa, Ana Gutierrez-Pecharoman, Rosa Villatoro, Bernardo Herrera, Raquel Correa, Adriana Rosero, María I Pacheco, Teresa Garcés, Ylenia Cendón, Ma Paz Nombela, Floortje Van de Poll, Gala Grau, Leticia Rivera, Pedro P López, Juan-Jesús Cruz, David Lorente, Gerhardt Attard, Elena Castro, David Olmos
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study). British journal of cancer 119 (9) (2018)